Remove Big Data Remove Clinical Research Remove Engineer Remove Life Science
article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Attendees will learn more about how an SCA was used at the design and execution phases in a recent study of new treatments for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) and will also receive an eBook ‘How to harness the potential of AI and real-world data for clinical research’. About the panel.

article thumbnail

Drug discovery in 2023: Five key predictions

Drug Discovery World

As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. There will be greater emphasis on diversity in clinical trials. In summary, 2023 could be a very exciting year for life sciences. M&A activity will accelerate.

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Genmab’s Silver Anniversary: Reflecting on 25 Years of Breakthroughs in Antibody Therapeutics

XTalks

As we explore Genmab’s strategic vision, technological advancements and the next frontier in antibody research, we gain insights into the future of medicine — a future where Genmab’s cutting-edge therapies are poised to transform patient care and meet the complex challenges of the next generation of healthcare.

article thumbnail

AI, big data and real world evidence – the challenges and opportunities

pharmaphorum

The webinar explored the potential of the technology to process the vast amount of data languishing untapped in EHRs, while ensuring that patient data privacy and safety is maintained at all times. BREATHE’s Jenni Quint said that the power is not just in information from wearables but the ability to link them with other data.

Big Data 135
article thumbnail

How big data analytics can make personalised care a reality

Drug Discovery World

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

article thumbnail

The rise of real-world evidence: unlocking the potential in EHRs

pharmaphorum

International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health records (EHRs) using artificial intelligence (AI) and clinical Natural Language Processing (NLP) techniques. AI use in the pandemic.

Doctors 116
article thumbnail

Syntegra Partnering with National Institutes of Health (NIH) and the Bill and Melinda Gates Foundation to Democratize Access to the Largest Set of COVID-19 Patient Records

The Pharma Data

There has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent. rows of data. There has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent. rows of data. About Syntegra.